Sabra Healthcare REIT (NASDAQ:SBRA) Posts Quarterly Earnings Results

Sabra Healthcare REIT (NASDAQ:SBRA) issued its earnings results on Wednesday. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting the consensus estimate of $0.16, Zacks reports. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The business had revenue of $221.75 million during the quarter, compared to analysts’ expectations of $204.53 million. During the same period in the prior year, the business earned $0.37 EPS. The business’s revenue for the quarter was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT updated its FY 2026 guidance to 1.550-1.590 EPS.

Sabra Healthcare REIT Stock Up 1.2%

NASDAQ:SBRA traded up $0.25 during mid-day trading on Thursday, hitting $20.60. 1,667,007 shares of the company’s stock traded hands, compared to its average volume of 2,569,538. The company has a fifty day moving average of $20.22 and a 200 day moving average of $19.32. Sabra Healthcare REIT has a twelve month low of $17.04 and a twelve month high of $21.07. The company has a market capitalization of $5.19 billion, a P/E ratio of 32.18, a P/E/G ratio of 1.62 and a beta of 0.67. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.29 and a current ratio of 4.29.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Friday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.8%. The ex-dividend date of this dividend is Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 187.50%.

Wall Street Analyst Weigh In

SBRA has been the subject of several research reports. Citizens Jmp upped their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 18th. Cantor Fitzgerald upped their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 17th. Wells Fargo & Company upped their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “overweight” rating in a research note on Thursday, March 26th. Citigroup upped their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Finally, Truist Financial upped their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Friday, March 13th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in SBRA. Balyasny Asset Management L.P. acquired a new position in Sabra Healthcare REIT during the 2nd quarter valued at about $49,955,000. Freestone Grove Partners LP acquired a new position in Sabra Healthcare REIT during the 4th quarter valued at about $34,862,000. Millennium Management LLC increased its position in Sabra Healthcare REIT by 197.5% during the 4th quarter. Millennium Management LLC now owns 2,668,429 shares of the real estate investment trust’s stock valued at $50,540,000 after buying an additional 1,771,342 shares in the last quarter. Nuveen LLC increased its position in Sabra Healthcare REIT by 28.6% during the 4th quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock valued at $138,324,000 after buying an additional 1,625,072 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Sabra Healthcare REIT during the 4th quarter valued at about $28,512,000. 99.40% of the stock is owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.